Keziah is a Torres Strait Islander woman and Director of Guunu-maana (Heal) Aboriginal and Torres Strait Islander Health Program at The George Institute for Global Health. Keziah is a Future Women Emerging Leader, and sits on the Association of Australian Medical Research Institute's Gender, Equity, Diversity and Inclusion committee. Keziah chairs the George Institute's Global Research and Impact Committee and has chaired the Research Committee for Aboriginal and Torres Strait Islander Health since 2017. She leads the development and implementation of Aboriginal and Torres Strait Islander health research strategy, policy, stakeholder partnerships and Indigenous research coordination within a global research institute.

Keziah has extensive experience in social and cultural determinants of health, Indigenous methodologies, and knowledge translation and impact measurement that privilege Indigenous knowledges, as well as applying decolonising methods to organisation and systems change. Keziah is a recognised leader in implementation of strategic organisational activities to increase cultural safety and capability within global health research.

A/Prof Laura Downey leads The George Institute’s global program for Universal Health Coverage (UHC). She is a conjoint Associate Professor in health economics and policy in the School of Population Health at UNSW, and an Advanced Research Fellow in the School of Public Health at Imperial College London, UK.

Dr Downey's research is focused broadly on evaluating health system performance in relation to UHC goals, and developing innovative solutions to support equitable access to high quality, affordable care for the world's most at-risk populations. She is a passionate advocate for health equity, and in particular gender equity, where she uses data to champion greater visibility of women's health issues and more inclusive and participatory evidence to policy processes. She is a Senior Investigator and the Capacity Strengthening co-lead of a £10million NIHR Global Health Research Centre for Non-Communicable Diseases and Environmental Change, where her research focuses on community-driven multisectoral intervention design, delivery, and evaluation to strengthen health systems to protect populations in India, Indonesia, and Bangladesh from environmental issues such as extreme heat and air pollution. She is an active invited advisor to the World Health Organisation (WHO) and currently a member of the WHO advisory group for the use of Glucagon-like Peptide Receptor Agonists (GLP1-RAs) for the management of obesity. She was an invited expert member of the Health Economics advisory group to the UK Infected Blood Inquiry (2020-2024), whose work directly informed recommendations made by the Inquiry Chair to the UK Government on behalf of the tens of thousands of individuals who were infected with HIV and Hepatitis A, B, and C by the National Health Service. She was an advisor to the Indian federal government between 2015 -2019 to support the establishment of a core Health Technology Assessment (HTA) function within the Ministry of Health and Family Welfare and remains an active advisor to the Indian Institute of Public Health, the Indian Council of Medical Research, and numerous State governments across India.

Dr Downey has active research collaborators across Asia, Africa, and Europe and has worked in partnership with global institutions such as the World Health Organisation, the Bill and Melinda Gates Foundation, The Asian Development Bank, and the World Bank. She has held previous positions with the National Institute of Health and Care Excellence (NICE) UK, the Centre for Global Development Europe, and University College London.

Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.